Sort
326,823 grants matching “clinical trial”
Primary Immune Deficiency Treatment Consortium
$1,846,474Jennifer Maxwell Puck · University Of California, San Francisco · U54 · FY2021 · AI
Hematopoietic Chimerism after Stem Cell Allografts
$1,846,366Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2014 · CA
Penn PET Addiction Center of Excellence (Penn PACE)
$1,846,343Robert H Mach · University Of Pennsylvania · P30 · FY2021 · DA
Primary Immune Deficiency Treatment Consortium
$1,846,257Jennifer Maxwell Puck · University Of California, San Francisco · U54 · FY2023 · AI
Primary Immune Deficiency Treatment Consortium
$1,846,257Jennifer Maxwell Puck · University Of California, San Francisco · U54 · FY2022 · AI
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
$1,846,248Matthew L Meyerson · Dana-Farber Cancer Inst · P01 · FY2017 · CA
Development of Adrb3 Antagonists for the Treatment of Pain
$1,846,202Andrea G Nackley · Duke University · R61 · FY2023 · NS
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
$1,846,173Matthew L Meyerson · Dana-Farber Cancer Inst · P01 · FY2020 · CA
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
$1,846,173Matthew L Meyerson · Dana-Farber Cancer Inst · P01 · FY2018 · CA
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
$1,846,173Matthew L Meyerson · Dana-Farber Cancer Inst · P01 · FY2021 · CA
Innate Immunity: Elucidation/Modulation - Cancer Therapy
$1,846,087Ohio State University · P01 · FY2003 · CA
Population Genetics Analysis Program: Immunity to Vaccines and Infections
$1,845,910Richard A. Kaslow · University Of Alabama At Birmingham · N01 · FY2011 · AI
Clinical Research Support Core
$1,845,830Francis Sessions Cole · Harvard Medical School · U2C · FY2025 · NS
Aging Well, Sleeping Efficiently
$1,845,550Timothy H. Monk · University Of Pittsburgh At Pittsburgh · P01 · FY2012 · AG
Deciphering the efficacy of posttransplant cyclophosphamide in BMT
$1,845,452Christopher Kanakry · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Bcl-2 and Mcl-1 inhibition for induction of hematopoietic chimerism and renal allograft tolerance without myelosuppression in nonhuman primates
$1,845,438Tatsuo Kawai · Massachusetts General Hospital · R01 · FY2025 · AI
I-SPY2 +: Evolving the I-SPY 2 TRIAL to include MRI-directed, adaptive sequential treatment to optimize breast cancer outcomes
$1,845,433Laura J Esserman · University Of California, San Francisco · P01 · FY2020 · CA
Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens
$1,845,039William C Hahn · Dana-Farber Cancer Inst · U01 · FY2017 · CA
CURE CTU
$1,845,017Stephen A Spector · University Of California, San Diego · UM1 · FY2025 · AI
CLINICAL TRIAL FOR COMMUNITY-ACQUIRED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
$1,845,000Andrew Boulter · University Of California, San Francisco · N01 · FY2014 · AI
Functional MRI Method Development
$1,844,995Peter Bandettini · National Institute Of Mental Health · ZIA · FY2009 · MH
Project 1: Development of Nucleoside-Modified mRNAs Encoding Sequential HIV-1 Envelopes for Initiation of V3-glycan Neutralizing Antibody Lineages
$1,844,691Barton F Haynes · Duke University · U19 · FY2019 · AI
Noroviruses and Epidemic Gastroenteritis
$1,844,686Kim Y. Green · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Quality Assurance Review Center
$1,844,678Thomas J Fitzgerald · Univ Of Massachusetts Med Sch Worcester · U10 · FY2010 · CA
Mechanisms of non-classical multidrug resistance in cancer
$1,844,598Michael Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA